1. Home
  2. EMN vs ICLR Comparison

EMN vs ICLR Comparison

Compare EMN & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Chemical Company

EMN

Eastman Chemical Company

HOLD

Current Price

$65.55

Market Cap

8.3B

Sector

Industrials

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$168.52

Market Cap

13.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMN
ICLR
Founded
1920
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
13.1B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
EMN
ICLR
Price
$65.55
$168.52
Analyst Decision
Buy
Buy
Analyst Count
13
13
Target Price
$79.31
$178.62
AVG Volume (30 Days)
896.2K
746.4K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
4.77%
N/A
EPS Growth
N/A
N/A
EPS
2.51
N/A
Revenue
$8,752,000,000.00
N/A
Revenue This Year
$3.06
N/A
Revenue Next Year
$3.47
N/A
P/E Ratio
$26.12
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$56.11
$66.57
52 Week High
$83.47
$203.91

Technical Indicators

Market Signals
Indicator
EMN
ICLR
Relative Strength Index (RSI) 33.04 51.70
Support Level $62.26 $162.06
Resistance Level $66.10 $183.11
Average True Range (ATR) 1.65 6.13
MACD -0.57 0.29
Stochastic Oscillator 9.60 55.72

Price Performance

Historical Comparison
EMN
ICLR

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: